U.S. markets open in 18 minutes
  • S&P Futures

    3,667.75
    +0.50 (+0.01%)
     
  • Dow Futures

    29,901.00
    +33.00 (+0.11%)
     
  • Nasdaq Futures

    12,471.50
    +17.25 (+0.14%)
     
  • Russell 2000 Futures

    1,839.10
    +1.60 (+0.09%)
     
  • Crude Oil

    45.09
    -0.19 (-0.42%)
     
  • Gold

    1,840.80
    +10.60 (+0.58%)
     
  • Silver

    23.99
    -0.09 (-0.39%)
     
  • EUR/USD

    1.2162
    +0.0047 (+0.39%)
     
  • 10-Yr Bond

    0.9330
    -0.0150 (-1.58%)
     
  • Vix

    20.97
    +0.20 (+0.96%)
     
  • GBP/USD

    1.3471
    +0.0095 (+0.71%)
     
  • USD/JPY

    103.9730
    -0.4510 (-0.43%)
     
  • BTC-USD

    19,337.05
    +387.80 (+2.05%)
     
  • CMC Crypto 200

    380.17
    +15.25 (+4.18%)
     
  • FTSE 100

    6,463.21
    -0.18 (-0.00%)
     
  • Nikkei 225

    26,809.37
    +8.39 (+0.03%)
     

U.S. FDA approves the Medicines Co's pain drug device Ionsys

April 30 (Reuters) - The U.S. Food and Drug Administration approved the Medicines Co's drug device, Ionsys, for postoperative pain for hospital use, the company said on Thursday.

Ionsys, a needleless, patient-controlled opioid-based treatment offers patients recovering from surgery in the hospital control over their analgesic dosing.

(Reporting by Natalie Grover and Samantha Kareen Nair in Bengaluru; Editing by Lisa Shumaker)